For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Infirst Healthcare Limited

USPTO Granted Patents = 52

EPO Patents = 9

Trademarks = 9

Forward Citations = 837

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

John Brew (52 out of 61 patents)

Robin Mark Bannister (52 out of 76 patents)

Wilson Caparros Wanderley (23 out of 23 patents)

4. Richard R Reiley, Iii (22 out of 22 patents)

5. Gregory Alan Stoloff (17 out of 42 patents)

6. Suzanne Jane Dilly (17 out of 23 patents)

7. Wilson Romero Caparros-Wanderley (12 out of 28 patents)

8. Gemma Szucs (10 out of 10 patents)

9. Olga Pleguezuelos Mateo (10 out of 11 patents)

10. Wilson Caparros-Wanderely (4 out of 4 patents)

11. Olga Pleguezeulos Mateo (4 out of 4 patents)

12. Richard Robert Reiley (0 patent)

13. Wilson CAPARRÓS-Wanderley (0 patent)

14. Richard Robert Reiley (0 patent)

15. Wilson CAPARRÓS-Wanderley (0 patent)

Core Competencies:

Solid Solution Compositions

Chronic Inflammation

Severe Pain

Cannabidiols

Cardiovascular Disease

Non-Steroidal Anti-Inflammatory Drug

Drug Combinations

Coughing Condition

Inflammatory Diseases

Oral Suspensions

Compositions for Treating Pain

Compositions for Treating Diseases

52 patents: Sort by Forward Citations

1. 11992555 - Solid solution compositions and use in chronic inflammation (2024-05-28),

2. 11918654 - Solid solution compositions and use in severe pain (2024-03-05),

3. 11844773 - Solid solution compositions and use in chronic inflammation (2023-12-19),

4. 11826428 - Solid solution compositions comprising cannabidiols (2023-11-28),

5. 11730709 - Compositions and methods for treating severe pain (2023-08-22),

6. 11660276 - Compositions and methods for treating chronic inflammation and inflammatory diseases (2023-05-30),

7. 11224659 - Solid solution compositions and use in severe pain (2022-01-18),

8. 11202831 - Solid solution compositions and use in cardiovascular disease (2021-12-21),

9. 11154500 - Solid solution compositions and use in chronic inflammation (2021-10-26),

10. 11103472 - Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID) (2021-08-31),

11. 11065218 - Compositions and methods for treating chronic inflammation and inflammatory diseases (2021-07-20),

12. 11000493 - Solid solution compositions and use in chronic inflammation (2021-05-11),

13. 10857114 - Compositions and methods for treating severe pain (2020-12-08),

14. 10849869 - Compositions and methods for treating chronic inflammation and inflammatory diseases (2020-12-01),

15. 10835490 - Solid solution compositions and use in chronic inflammation (2020-11-17),

Infirst Healthcare Limited is a pharmaceutical company specializing in the development and commercialization of innovative healthcare products. We strive to improve patient outcomes and enhance quality of life through our advanced therapies. With a focus on research and development, we aim to address critical medical needs and bring new, effective treatments to market. Our team of dedicated professionals is committed to driving innovation in the healthcare industry and providing accessible, reliable medications to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

52 Patents

#64 in London

#329 in United Kingdom

#13,161 in the World

London, United Kingdom

Infirst Healthcare Limited

Forward Citations = 837

11 inventors:

John Brew (52 out of 61 patents)

Robin Mark Bannister (52 out of 76 patents)

Wilson Caparros Wanderley (23 out of 23 patents)

4. Richard R Reiley, Iii (22 out of 22 patents)

5. Gregory Alan Stoloff (17 out of 42 patents)

Please report any incorrect information to support@idiyas.com

Loading…